Capacity for cortical excitation is reduced in psychotic disorders: An investigation of the TMS-EMG cortical silent period

Fleur M. Howells; Jennifer H. Hsieh; Henk Temmingh; David S. Baldwin; Dan Joseph Stein

doi:10.1016/j.schres.2021.12.012

Back

Capacity for cortical excitation is reduced in psychotic disorders: An investigation of the TMS-EMG cortical silent period

Letter 2021 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

The prevalence and clinical correlates of substance use disorders in patients with psychotic disorders from an Upper-Middle-Income Country

Henk Temmingh, Sumaya Mall, Fleur M. Howells, Goodman Sibeko, Dan Joseph Stein

Article2025

Joint detection of risk for psychotic disorders or bipolar disorders in clinical practice in the UK: development and validation of a clinical prediction model

Maite Arribas, Andrea De Micheli, Kamil Krakowski, Daniel Ståhl, Christoph U. Correll, Allan H Young, Ole A. Andreassen, Eduard Vieta, Celso Arango, Philip McGuire, Dominic Oliver, Laura Fusar‐Poli

Article2009

Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration

Evangelos Terpos, Eirini Katodritou, E. Tsiftsakis, Efstathios Kastritis, D. Christoulas, Anastasia Pouli, Eurydiki Michalis, Eugenia Verrou, Konstantinos Anargyrou, Konstantinos Tsionos, Meletios A Dimopoulos, Konstantinos Zervas

Article1997

The contribution of biological factors to the pathogenesis of psychiatric disorders in the postpartum period: a survey

M. Claes, Michael Maes, Yves Jacquemyn

Article2004

Capacity for cortical excitation is reduced in psychotic disorders: An investigation of the TMS-EMG cortical silent period

Discussion(0)

Related publications

The prevalence and clinical correlates of substance use disorders in patients with psychotic disorders from an Upper-Middle-Income Country

Joint detection of risk for psychotic disorders or bipolar disorders in clinical practice in the UK: development and validation of a clinical prediction model

Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration

The contribution of biological factors to the pathogenesis of psychiatric disorders in the postpartum period: a survey

The analyses of pre-arcing period and modeling of a high breaking capacity fuse-link in SABER